T
Teresa López Fernández
Researcher at Hospital Universitario La Paz
Publications - 38
Citations - 3797
Teresa López Fernández is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Cardiotoxicity & Medicine. The author has an hindex of 11, co-authored 32 publications receiving 2526 citations.
Papers
More filters
Journal ArticleDOI
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
José Luis Zamorano,Patrizio Lancellotti,Daniel Rodriguez Muñoz,Victor Aboyans,Riccardo Asteggiano,Maurizio Galderisi,Gilbert Habib,Daniel J. Lenihan,Gregory Y.H. Lip,Alexander R. Lyon,Teresa López Fernández,Dania Mohty,Massimo F. Piepoli,Juan Tamargo,Adam Torbicki,Thomas M. Suter +15 more
TL;DR: This document describes the development and use of angiotensin-converting enzyme, a non-volatile substance that acts as a “spatially aggregating substance” to reduce the chances of heart attack in women.
Journal ArticleDOI
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
José Luis Zamorano,Patrizio Lancellotti,Daniel Rodriguez Muñoz,Victor Aboyans,Riccardo Asteggiano,Maurizio Galderisi,Gilbert Habib,Daniel J. Lenihan,Gregory Y.H. Lip,Alexander R. Lyon,Teresa López Fernández,Dania Mohty,Massimo F. Piepoli,Juan Tamargo,Adam Torbicki,Thomas M. Suter,Stephan Achenbach,Stefan Agewall,Lina Badimon,Gonzalo Barón-Esquivias,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Scipione Carerj,Veronica Dean,Çetin Erol,Donna Fitzsimons,Oliver Gaemperli,Paulus Kirchhof,Philippe Kolh,Petros Nihoyannopoulos,Piotr Ponikowski,Marco Roffi,Antonio Vaz Carneiro,Stephan Windecker +34 more
TL;DR: No abstract available Keywords: European Society of Cardiology; arrhythmias; cancer therapy; cardio-oncology; cardiotoxicity; chemotherapy; early detection; ischaemia; myocardial dysfunction; surveillance.
Journal ArticleDOI
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Radek Pudil,Christian Mueller,Jelena Čelutkienė,Peter A. Henriksen,Dan Lenihan,Susan Dent,Ana Barac,Susanna Stanway,Javid Moslehi,Thomas M. Suter,Bonnie Ky,Martin Štěrba,Daniela Cardinale,Alain Cohen-Solal,Carlo G. Tocchetti,Dimitrios Farmakis,Dimitrios Farmakis,Jutta Bergler-Klein,Markus S. Anker,Stephan von Haehling,Y N Belenkov,Zaza Iakobishvili,Christoph Maack,Fortunato Ciardiello,Frank Ruschitzka,Andrew J.S. Coats,Petar M. Seferovic,Mitja Lainscak,Massimo F Piepoli,Ovidiu Chioncel,Jereon Bax,Jean-Sébastien Hulot,Hadi Skouri,Eva Simona Hägler-Laube,Riccardo Asteggiano,Teresa López Fernández,Rudolf A. de Boer,Alexander R. Lyon +37 more
TL;DR: Novel surveillance clinical pathways integrating cardiac biomarkers for cancer patients receiving anthracycline chemotherapy or trastuzumab biomarkers are presented and future direction in cardio‐oncology biomarker research is discussed.
Journal ArticleDOI
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry.
Jose Lopez-Sendon,Carlos Álvarez-Ortega,Pilar Zamora Auñón,Antonio Buño Soto,Alexander R. Lyon,Dimitrios Farmakis,Dimitrios Farmakis,Daniela Cardinale,Miguel Canales Albendea,Jaime Feliu Batlle,Isabel Rodríguez Rodríguez,Olaia Rodríguez Fraga,Ainara Albaladejo,Guiomar Mediavilla,José Ramón González-Juanatey,Amparo Martínez Monzonis,Pilar Gómez Prieto,José González-Costello,José María Serrano Antolín,Rosalía Cadenas Chamorro,Teresa López Fernández +20 more
TL;DR: The majority of patients present objective data of myocardial injury/dysfunction during or after cancer therapy, but severe CTox, with a strong prognostic relationship, was comparatively rare and should be reflected in protocols for clinical and research practices.
Journal ArticleDOI
Stanowisko ESC dotyczace toksycznego wpływu leczenia onkologicznego na UKład sercowo-naczyniowy w 2016 roku, opracowane pod auspicjami Komisji ESC do spraw Wytycznych Post? Powania Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw toksycznego wpływu leczenia onkologicznego na UKład sercowo-naczyniowy
José Luis Zamorano,Patrizio Lancellotti,Daniel Muñoz,Victor Aboyans,Riccardo Asteggiano,Maurizio Galderisi,Gilbert Habib,Daniel J. Lenihan,Gregory Y.H. Lip,Alexander R. Lyon,Teresa López Fernández,Dania Mohty,Massimo F Piepoli,Juan Tamargo,Adam Torbicki,Thomas M. Suter +15 more